Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1079857
Title:
VACCIN MIXTE B/C CONTRE LA MENINGITE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
999260466
WO application number:
US1999011977
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
1079857
WO publication number:
WO 1999/061053
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
28/05/1999
Grant date:
29/11/2006
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
02/02/2007
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/11/2006
EP B1 publication date:
29/11/2006
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/05/2018
Expiration date (if granted and all annual fees paid):
28/05/2019
Applicant
1
Name:
GlaxoSmithKline Biologicals S.A.
Legal Form:
From:
15/02/2018
Address:
rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
To:
2
Name:
The Norwegian Institute of Public Health
Legal Form:
From:
15/02/2018
Address:
PO Box 4404, 0403, Oslo, Norway (NO)
To:
3
Name:
NOVARTIS VACCINES AND DIAGNOSTICS INC.
Legal Form:
From:
29/11/2006
Address:
-, -, Unknown (UNKNOWN)
To:
21/05/2007
4
Name:
STATENS INSTITUTT FOR FOLKEHELSE
Legal Form:
From:
29/11/2006
Address:
-, -, Unknown (UNKNOWN)
To:
21/05/2007
5
Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
06/12/2017
Address:
2711 Centerville Road, Suite 400, Wilmington, DE 19808, United States (US)
To:
06/12/2017
6
Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
21/05/2007
Address:
4560 Horton Street,Emeryville, CA 94608, -, United States (US)
To:
06/12/2017
7
Name:
The Norwegian Institute of Public Health
Legal Form:
From:
21/05/2007
Address:
PO Box 4404, 0403, Oslo, Norway (NO)
To:
06/12/2017
8
Name:
The Norwegian Institute of Public Health
Legal Form:
From:
06/12/2017
Address:
PO Box 4404, 0403, Oslo, Norway (NO)
To:
06/12/2017
9
Name:
The Norwegian Institute of Public Health
Legal Form:
From:
06/12/2017
Address:
PO Box 4404, 0403, Oslo, Norway (NO)
To:
15/02/2018
10
Name:
GlaxoSmithKline Biologicals s.a.
Legal Form:
From:
06/12/2017
Address:
rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
To:
15/02/2018
Agent
1
Name:
KIRKPATRICK
Legal Form:
From:
23/12/2020
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)